Opaleye Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-210,000	Closed	-$9.83M	–	54
2024 Q1	$9.83M	Sell	210,000 -97,500	-32%	-$4.56M	2.14%	16
2023 Q4	$10.9M	Sell	307,500 -62,500	-17%	-$2.22M	2.91%	10
2023 Q3	$11M	Sell	370,000 -475,000	-56%	-$14.1M	3.58%	9
2023 Q2	$15.2M	Buy	845,000 +59,206	+8%	+$1.07M	3.64%	5
2023 Q1	$12.6M	Buy	785,794 +53,794	+7%	+$864K	3.78%	5
2022 Q4	$13.4M	Buy	732,000 +60,700	+9%	+$1.11M	4.66%	5
2022 Q3	$13.2M	Hold	671,300	–	–	5.45%	5
2022 Q2	$12.5M	Sell	671,300 -21,700	-3%	-$405K	5.64%	4
2022 Q1	$15.2M	Sell	693,000 -31,400	-4%	-$689K	4.72%	5
2021 Q4	$20.6M	Buy	724,400 +322,287	+80%	+$9.16M	4.36%	7
2021 Q3	$8.46M	Buy	402,113 +201,613	+101%	+$4.24M	1.58%	21
2021 Q2	$3.78M	Buy	200,500 +12,500	+7%	+$236K	0.63%	39
2021 Q1	$2.87M	Buy	+188,000	New	+$2.87M	0.42%	47
2020 Q4	–	Sell	-240,000	Closed	-$3.76M	–	61
2020 Q3	$3.76M	Sell	240,000 -195,200	-45%	-$3.06M	0.74%	36
2020 Q2	$7.63M	Buy	435,200 +66,450	+18%	+$1.16M	1.54%	24
2020 Q1	$5.42M	Buy	368,750 +102,650	+39%	+$1.51M	1.44%	21
2019 Q4	$6.68M	Buy	266,100 +59,100	+29%	+$1.48M	1.31%	33
2019 Q3	$3.11M	Buy	207,000 +171,000	+475%	+$2.57M	1.13%	32
2019 Q2	$900K	Sell	36,000 -37,000	-51%	-$925K	0.27%	40
2019 Q1	$1.66M	Buy	+73,000	New	+$1.66M	0.46%	46